Investigation of chromosomal aberrations in hepatocellular carcinoma by fluorescence in situ hybridization

Cancer Genetics and Cytogenetics

Volumn 111, Issue 1, 1999, Pages 21-27

  Huang, Shiu Feng ^a   Hsu, Hey Chi ^a   Fletcher, Jonathan A ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME 6Q; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PLOIDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 0032946214     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00215-5     Document Type: Article

References (47)

1. Simon D., Munoz S.J., Maddrey W.C., Knowles B. Chromosomal rearrangements in a primary hepatocellular carcinoma. Cancer Genet Cytogenet. 45:1990;255-260.
2. Bardi G., Johanson B., Pandis N., Heim S., Mandahl N., Andrén-Sandberg A., Hagerstrand I., Mitelman F. Cytogenetic findings in three primary hepatcellular carcinomas. Cancer Genet Cytogenet. 58:1992;191-195.
3. Chen H.L., Chen Y.C., Chen D.S. Chromosome 1p aberrations are frequent in human primary hepatocellular carcinoma. Cancer Genet Cytogenet. 86:1996;102-106.
4. Lowichik A., Schneider N.R., Tonk V., Ansari M.Q., Timmons C.F. Report of a complex karyotype in recurrent metastatic fibrolamellar hepatocellular carcinoma and a review of hepatocellular carcinoma cytogenetics. Cancer Genet Cytogenet. 88:1996;170-174.
5. Yeh S.H., Chen P.J., Chen H.L., Lai M.Y., Wang C.C., Chen D.S. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res. 54:1994;4188-4192.
6. Kuroki T., Fujiwara Y., Tsuchiya E., Nakamori S., Imaoka S., Kanematsu T., Nakamura Y. Accumulation of genetic changes during development and progression of hepatocellur carcinoma. loss of heterozygosity on chromosome arm 1p occurs at an early stage of hepatocarcinogenesis Genes Chromosom Cancer. 13:1995;163-167.
7. Simon D., Knowles B.B., Weith A. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene. 6:1991;765-770.
8. Yeh S.H., Chen P.J., Lai M.Y., Chen D.S. Allelic loss on chromosome 4q and 16q in hepatocellular carcinoma. association with alpha-fetoprotein production Gastroenterology. 110:1996;184-192.
9. Zhang W., Hirohashi S., Tsuda H., Shimosato Y., Yokota J., Terada M., Sugimura T. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res. 81:1990;108-111.
10. Fujimori M., Tokino T., Hino O., Kitagawa T., Imamura T., Okamoto E., Mitsunobu M., Ishikawa T., Nakagama H., Harada H., Yagura M., Matsubara K., Nakamura Y. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 51:1991;89-93.
11. De Souza A.T., Hankins G.R., Washington M.K., Fine R.L., Orton T.C., Jirtle R.L. Frequent loss of heterozygosity on 6q at the mannose 6-phosphate/insulin-like growth factor II receptor locus in human hepatocellular tumors. Oncogene. 10:1995;1725-1729.
12. De Souza A.T., Hankins G.R., Washington M.K., Orton T.C., Jirtle R.L. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet. 11:1995;447-449.
13. Emi M., Fujiwara Y., Nakajima T., Tsuchia E., Tsuda H., Hirohashi S., Maeda Y., Tsuruta K., Miyaki M., Nakamura Y. Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res. 52:1992;5368-5372.
14. Emi M., Fujiwara Y., Ohata H., Tsuda H., Hirohashi S., Koike M., Miyaki M., Monden M., Nakamura Y. Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosom Cancer. 7:1993;152-157.
15. Wang H.P., Rogler C.E. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet Cell Genet. 48:1988;72-78.
16. Nishida N., Fukuda Y., Kokuryu H., Sadamoto T., Isowa G., Honda K., Yamaoka Y., Ikenaga M., Imura H., Ishizaki K. Accumulation of allelic loss on arms of chromosomes 13q, 16q, and 1p in the advanced stages of human hepatocellular carcinoma. Int J Cancer. 51:1992;862-868.
17. Zhang X., Xu H.J., Murakami Y., Sachse R., Yashima K., Hirohashi S., Hu S.X., Benedict W.F., Sekiya T. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res. 54:1994;4177-4182.
18. Nose H., Imazeki F., Ohto M., Omata M. p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer. 72:1993;355-360.
19. Takahashi K., Kudo J., Ishibashi H., Hirata Y., Hino Y. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma. Hepatology. 17:1993;794-799.
20. Marchio A., Meddeb M., Pineau P., Danglot G., Tiollais P., Berheim A., Deiean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosom Cancer. 18:1997;59-65.
21. Boige V., Laurent-Puig P., Fouchet P., Fléjou J.F., Monges G., Bedossa P., Bioulac-Sage P., Capron F., Schmitz A., Olschwang S., Thomas G. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res. 57:1997;1986-1990.
22. Nagai H., Pineau P., Tiollais P., Buendia M.A., Dejean A. Comprehensive allelotyping of human hepatcellular carcinoma. Oncogene. 14:1997;2927-2933.
23. Huang S.F., Xiao S., Renshaw A.A., Loughlin K.R., Hudson T.J., Fletcher J.A. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer. Am J Pathol. 149:1996;1565-1573.
24. Merlo A., Gabielson E., Mabry M., Vollmer R., Baylin S.B., Sidransky D. Homozygous deletion on chromosome 9p and loss of heterozygosity on 9q, 6p and 6q in primary human small cell lung cancer. Cancer Res. 54:1994;2322-2326.
25. Menasce L.P., Orphanos V., Santibanez-Koref M., Boyle J.M., Harrison C.J. Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukemia. Genes Chromosom Cancer. 10:1994;286-288.
26. Orphanos V., McGown G., Hey Y., Boyle J.M., Santibanez-Koref M. Proximal 6q, a region showing allele loss in primary breast cancer. Br J Cancer. 71:1995;290-293.
27. Nasarek A., Werner M., Nolte M., Klempnauer J., Georgii A. Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. a fluorescence in situ hybridization study Virchows Arch. 427:1995;373-378.
28. Kimura H., Kagawa K., Deguchi T., Nakajima T., Kakushi M., Okawara T., Katagishi T., Okanoue T., Kashima K., Ashihara T. Cytogenetic analyses of hepatocellular carcinoma by in situ hybridization with a chromosome-specific DNA probe. Cancer. 77:1996;271-277.
29. Hamon-Benais C., Ingster O., Terris B., Couturier-Turpin M.H., Berheim A., Feldmann G. Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescence in situ hybridization. Hepatology. 23:1996;429-435.
30. Kato A., Kubo K., Kurokawa F., Okita K., Oga A., Murakami T. Numerical aberrations of chromosomes 16, 17, and 18 in hepatocellular carcinoma. a FISH and FCM analysis of 20 cases Digest Dis Sci. 43:1998;1-7.
31. Terris B., Ingster O., Rubbia L., Dubois S., Belghiti J., Feldmann G., Degott C., Henin D. Interphase cytogenetic analysis reveals numerical chromosome aberrations in large liver cell dysplasia. J Hepatol. 27:1997;313-319.
32. Ohasawa N., Sakamoto M., Saito T., Kobayashi M., Hirohashi S. Numerical chromosome aberrations in hepatocellular carcinoma detected by fluorescence in situ hybridization. J Hepatol. 25:1996;655-662.
33. Dreyling M.H., Bohlander S.K., Adeyanju M.O., Olopade O.I. Detection of CDKN2 deletion in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res. 55:1995;984-988.
34. Xiao S., Renshaw A.A., Cibas E.S., Hudson T.J., Fletcher J.A. Novel fluorescence in situ hybridization approaches in solid tumors. characterization of frozen specimens, touch preparations, and cytologic preparations Am J Pathol. 147:1995;896-904.
35. Pandis N., Jin Y., Limon J., Bardi G., Idvall I., Mandahl N., Mitelman F., Heim S. Interstitial deletion of the short arm of chromosome 3 as a primary chromosome abnormality in carcinomas of the breast. Genes Chromosom Cancer. 6:1993;151-155.
36. Hibi K., Takahashi T., Yamakawa K., Ueda R., Sekido Y., Ariyoshi Y., Suyama M., Takagi H., Nakamura Y. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene. 7:1992;445-449.
37. Coleman A., Fountain J.W., Nobori T., Olopade O.I., Roberston G., Housman D.E., Lugo T.G. Distinct deletions of chromosome 9p associated with melanoma versus glioma, lung cancer, and leukemia. Cancer Res. 54:1994;344-348.
38. Hopman A.H., Ramaekers F.C., Raap A.K., Beck J.L., Devilee P., van der Ploeg M., Vooijs G.P. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry. 89:1988;307-316.
39. Buetow K.H., Murray J.C., Israel J.L., Lodon W.T., Smith M., Kew M., Blanquet V., Brechot C., Redeker A., Govindarajah S. Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA. 86:1989;8852-8856.
40. Walker J.G., Heyward N.K., Falvey S., Cooksley W.G.E. Loss of somatic heterozygosity in hepatocellular carcinoma. Cancer Res. 51:1991;4367-4370.
41. Bièche I., Lidereau R. Genetic alterations in breast cancer. Genes Chromosom Cancer. 14:1995;227-251.
42. Yaremko M.L., Recant W.M., Westbrook C.A. Loss of heterozygosity from the short arm of chromosome 8 is an early event in breast cancers. Genes Chromosom Cancer. 13:1995;186-191.
43. Vocke C.D., Pozzatti R.O., Bostwick D.G., Florence C.D., Jennings S.B., Strup S.E., Duray P.H., Liotta L.A., Emmert-Buck M.R., Linehan W.M. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res. 56:1996;2411-2416.
44. Nobori T., Miura K., Wu D.J., Lois A., Takabayashi K., Carson A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 368:1994;753-754.
45. Mori T., Miura K., Aoki T., Nishihira T., Mori S., Nakamura Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependnet kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res. 54:1994;3396-3397.
46. Xiao S., Li D., Vijg J., Sugarbaker D.J., Corson J.M., Fletcher J.A. Codeletion of p15 and p16 in primary malignant mesothelioma. Oncogene. 11:1995;511-515.
47. INK4 in hepatocellular carcinoma. Hepatology. 24:1996;575-579.